GENE ONLINE|News &
Opinion
Blog

2025-03-14|

Researchers Work on Portable Blood Test for Colon Cancer Detection

by Mark Chiang
Share To
Newsflash | Powered by GeneOnline AI

A team of researchers is developing a portable, blood-based device aimed at detecting colon cancer. The initiative seeks to provide an alternative to traditional colonoscopies, which are often described as uncomfortable, expensive, and occasionally associated with medical risks. According to the National Cancer Institute, colorectal cancer ranks as the second leading cause of cancer-related deaths in the United States, underscoring the importance of accessible and effective screening methods.

The proposed device would utilize a blood sample to identify markers associated with colon cancer. This approach could potentially simplify the screening process and make it more widely available. While details about the technology or its current stage of development were not disclosed in the announcement, researchers aim to address barriers that discourage individuals from undergoing routine colonoscopies. The effort aligns with ongoing public health goals to improve early detection rates and reduce mortality linked to colorectal cancers.

Date: 14 March, 2025

Newsflash | Powered by GeneOnline AI

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
R&D
A Harvard-led Colibactin Study Reveals How Gut Microbes Cross-Link DNA to Raise Colorectal Cancer Risk
2025-12-30
World AIDS Day 2025: Overcoming Disruption, Renewing Commitment to End AIDS by 2030
2025-12-01
Climate Extremes Heighten Diabetes Incidence, Hospitalizations and Mortality: Global Evidence and Implications
2025-11-13
LATEST
Generative AI Enhances Shanshui Animations with Perlin Noise and Diffusion Models
2026-01-16
QMSR Town Hall Discusses Integrating Risk Management into Product Design and Fostering Quality Culture in Pharma and Medical Devices
2026-01-16
Magnesium Oxychloride Cement from Dolomite Ore Developed with Self-Cleaning Properties
2026-01-16
New Database MitoCommun Developed to Map Mitochondrial Communication Networks
2026-01-16
New Model Combines Computational Methods and Pharmacological Knowledge to Predict Adverse Drug Interactions
2026-01-16
Tolerance Bio Targets Congenital Athymia with Therapies to Restore Thymus Function
2026-01-16
United States to Implement International Pricing Benchmarks for Drug Costs by 2026
2026-01-16
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
BIO Europe Spring (Biotech Partnering)
Lisbon, Portugal
Scroll to Top